These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Cancer Stemness: p53 at the Wheel. Ghatak D; Das Ghosh D; Roychoudhury S Front Oncol; 2020; 10():604124. PubMed ID: 33505918 [TBL] [Abstract][Full Text] [Related]
65. Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches. Alvarado-Ortiz E; de la Cruz-López KG; Becerril-Rico J; Sarabia-Sánchez MA; Ortiz-Sánchez E; García-Carrancá A Front Cell Dev Biol; 2020; 8():607670. PubMed ID: 33644030 [TBL] [Abstract][Full Text] [Related]
66. Cancer Cells Shuttle Extracellular Vesicles Containing Oncogenic Mutant p53 Proteins to the Tumor Microenvironment. Bhatta B; Luz I; Krueger C; Teo FX; Lane DP; Sabapathy K; Cooks T Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203762 [TBL] [Abstract][Full Text] [Related]
67. Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function. Zhao Y; Yue X; Hu W Mol Cell Oncol; 2016 Mar; 3(2):e1076587. PubMed ID: 27308598 [TBL] [Abstract][Full Text] [Related]
68. Mouse models of p53 functions. Lozano G Cold Spring Harb Perspect Biol; 2010 Apr; 2(4):a001115. PubMed ID: 20452944 [TBL] [Abstract][Full Text] [Related]
69. Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models. Wang J; Hu Y; Escamilla-Rivera V; Gonzalez CL; Tang L; Wang B; El-Naggar AK; Myers JN; Caulin C Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806894 [TBL] [Abstract][Full Text] [Related]
70. Gain of function of mutant p53: R282W on the peak? Zhang Y; Coillie SV; Fang JY; Xu J Oncogenesis; 2016 Feb; 5(2):e196. PubMed ID: 26878390 [TBL] [Abstract][Full Text] [Related]
71. Use of the DNA fiber spreading technique to detect the effects of mutant p53 on DNA replication. Frum RA; Deb S; Deb SP Methods Mol Biol; 2013; 962():147-55. PubMed ID: 23150444 [TBL] [Abstract][Full Text] [Related]
72. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma. Hu W; Ma SL; Qiong L; Du Y; Gong LP; Pan YH; Sun LP; Wen JY; Chen JN; Guan XY; Shao CK iScience; 2024 Mar; 27(3):109116. PubMed ID: 38384839 [TBL] [Abstract][Full Text] [Related]
73. The p53 "knockout": gone but not forgotten. Carbone D Hepatology; 1992 Oct; 16(4):1094-6. PubMed ID: 1398492 [No Abstract] [Full Text] [Related]
74. Gain-of-Function Variomics and Multi-omics Network Biology for Precision Medicine. Li MM; Awasthi S; Ghosh S; Bisht D; Coban Akdemir ZH; Sheynkman GM; Sahni N; Yi SS Methods Mol Biol; 2023; 2660():357-372. PubMed ID: 37191809 [TBL] [Abstract][Full Text] [Related]
75. Genomic instability and tumor progression: mechanistic considerations. Cheng KC; Loeb LA Adv Cancer Res; 1993; 60():121-56. PubMed ID: 8417498 [No Abstract] [Full Text] [Related]
76. Effects of p53 mutation on tumor progression: recent insights from mouse tumor models. Donehower LA Biochim Biophys Acta; 1996 Mar; 1242(3):171-6. PubMed ID: 8603069 [No Abstract] [Full Text] [Related]
77. Double minutes replicate once during S phase of the cell cycle. Barker PE; Drwinga HL; Hittelman WN; Maddox AM Exp Cell Res; 1980 Dec; 130(2):353-60. PubMed ID: 7449855 [No Abstract] [Full Text] [Related]
78. Inside the tumor: p53 modulates calcium homeostasis. Giorgi C; Bonora M; Pinton P Cell Cycle; 2015; 14(7):933-4. PubMed ID: 25715001 [No Abstract] [Full Text] [Related]
79. The Epistemic Value of Gain of Function Experiments. Casadevall A; Fang FC; Imperiale MJ mSphere; 2024 Jan; 9(1):e0071423. PubMed ID: 38132562 [TBL] [Abstract][Full Text] [Related]
80. Editorial: Advances in wild type and mutant p53 research in cancer. Hernández-de la Cruz ON; Domínguez-Gómez G; Deb M; Díaz-Chávez J Front Mol Biosci; 2022; 9():1064280. PubMed ID: 36438655 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]